×
S&P 500   3,802.97 (-0.49%)
DOW   30,923.97 (-0.07%)
QQQ   283.00 (-0.19%)
AAPL   139.22 (+1.30%)
MSFT   259.49 (+1.17%)
META   163.59 (+1.81%)
GOOGL   2,226.91 (-0.59%)
AMZN   108.94 (+1.43%)
TSLA   671.16 (-3.84%)
NVDA   154.01 (-3.64%)
NIO   21.53 (-3.71%)
BABA   115.48 (-1.10%)
AMD   76.95 (-4.74%)
MU   55.65 (-3.82%)
CGC   3.52 (-2.49%)
T   20.77 (+0.78%)
GE   64.08 (-2.73%)
F   11.47 (-2.88%)
DIS   95.20 (-0.75%)
AMC   13.44 (+0.45%)
PFE   50.94 (+0.55%)
PYPL   71.10 (-1.00%)
NFLX   176.69 (-1.62%)
S&P 500   3,802.97 (-0.49%)
DOW   30,923.97 (-0.07%)
QQQ   283.00 (-0.19%)
AAPL   139.22 (+1.30%)
MSFT   259.49 (+1.17%)
META   163.59 (+1.81%)
GOOGL   2,226.91 (-0.59%)
AMZN   108.94 (+1.43%)
TSLA   671.16 (-3.84%)
NVDA   154.01 (-3.64%)
NIO   21.53 (-3.71%)
BABA   115.48 (-1.10%)
AMD   76.95 (-4.74%)
MU   55.65 (-3.82%)
CGC   3.52 (-2.49%)
T   20.77 (+0.78%)
GE   64.08 (-2.73%)
F   11.47 (-2.88%)
DIS   95.20 (-0.75%)
AMC   13.44 (+0.45%)
PFE   50.94 (+0.55%)
PYPL   71.10 (-1.00%)
NFLX   176.69 (-1.62%)
S&P 500   3,802.97 (-0.49%)
DOW   30,923.97 (-0.07%)
QQQ   283.00 (-0.19%)
AAPL   139.22 (+1.30%)
MSFT   259.49 (+1.17%)
META   163.59 (+1.81%)
GOOGL   2,226.91 (-0.59%)
AMZN   108.94 (+1.43%)
TSLA   671.16 (-3.84%)
NVDA   154.01 (-3.64%)
NIO   21.53 (-3.71%)
BABA   115.48 (-1.10%)
AMD   76.95 (-4.74%)
MU   55.65 (-3.82%)
CGC   3.52 (-2.49%)
T   20.77 (+0.78%)
GE   64.08 (-2.73%)
F   11.47 (-2.88%)
DIS   95.20 (-0.75%)
AMC   13.44 (+0.45%)
PFE   50.94 (+0.55%)
PYPL   71.10 (-1.00%)
NFLX   176.69 (-1.62%)
S&P 500   3,802.97 (-0.49%)
DOW   30,923.97 (-0.07%)
QQQ   283.00 (-0.19%)
AAPL   139.22 (+1.30%)
MSFT   259.49 (+1.17%)
META   163.59 (+1.81%)
GOOGL   2,226.91 (-0.59%)
AMZN   108.94 (+1.43%)
TSLA   671.16 (-3.84%)
NVDA   154.01 (-3.64%)
NIO   21.53 (-3.71%)
BABA   115.48 (-1.10%)
AMD   76.95 (-4.74%)
MU   55.65 (-3.82%)
CGC   3.52 (-2.49%)
T   20.77 (+0.78%)
GE   64.08 (-2.73%)
F   11.47 (-2.88%)
DIS   95.20 (-0.75%)
AMC   13.44 (+0.45%)
PFE   50.94 (+0.55%)
PYPL   71.10 (-1.00%)
NFLX   176.69 (-1.62%)

Bed Bath & Beyond Uncovers The Problem With Q1 Earnings Season

Thursday, April 14, 2022 | Thomas Hughes
Bed Bath & Beyond Uncovers The Problem With Q1 Earnings Season

Supply Chain Disruption Sucks Wind From Bed Bath & Beyond Recovery 

Bed Bath & Beyond (NASDAQ: BBBY) had a horrible quarter impacted by supply chain disruptions that have its inventory in transit or sitting in port. As bad as the news is for Bed Bath & Beyond investors the repercussion for the market is much more severe. If the situation develops into a trend and there is no reason to think it won’t, results from a broad array of sectors could come in well below forecast. We’re not sure how conditions are in all parts of the US but store shelves around our neck of the woods have more gaps than ever. 

"Macroeconomic factors, such as the disruption of the global supply chain, the Omicron variant, as well as the geopolitical turbulence weighing on consumer confidence, have uncovered more vulnerabilities than we could have foreseen at this stage of our transformation, as we completely rebuild the foundation of our business,” says CEO Mark Tritton. 

Bed Bath And Beyond Gets Dunked In Q1 

Bed Bath And Beyond was expected to post a large decline in YOY revenue due to factors that include tough comps, no stimulus tailwind, and store closures as a result of the turnaround plan. The bad news is the $2.05 billion in revenue is down 21.8% from last year and missed the consensus by 150 basis points. The decline is driven by a 12% reduction in comp sales versus the expected 8.5% and an 18% shortfall in eCommerce sales. 

"The lack of available inventory to sell proved to be a continuing impediment to sales through the remainder of the fourth quarter and into the early part of fiscal 2022 …  We estimate an impact of approximately $175 million to our fourth-quarter sales, or a high-single-digit deficit, as a result of a lack of in-stock availability in our Bed Bath banner. Positive product-related margin expansion associated with our Owned Brands, pricing, and promo optimization were offset by escalating supply chain costs. "


Moving on to the income, the company reported a 400 basis point contraction in the gross margin that was at least offset by an improvement in SG&A expense. The bad news is the company incurred a net loss for the quarter that resulted in adjusted earnings of -$0.92 or $0.95 weaker than the Marketbeat.com consensus. The good news is the loss is due to special items related to restructuring and turnaround and will not be recurring. The bad news is the company was unable to give more than optimistic guidance and it is one fraught with risk. Full-year results are expected to show YOY improvement due to the expected supply chain improvement in the back half of 2022. The back half of F2022 is a long way away. 

The Technical Outlook: BBBY Slips And May Not Be Able To Get Up 

Shares of BBBY fell more than 10% on the Q4 news but buyers were there to meet the fall. The bad news is that buying may be more because of short-covering than real buying so the rebound is not likely to last. In our view, price action may rebound to the short-term moving average near $20.50 but we do not expect to see it move much higher. While there is a positive outlook for the back half of the year, Bed Bath & Beyond needs to get through two-quarters of the first half and we think they will be tough quarters indeed. The supply chain may catch up, but just in time for inflation to curb demand. If the shorts get active again, this stock could retest the recent low near $12.50 or lower. 

Bed Bath & Beyond Uncovers The Problem With Q1 Earnings 

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Bed Bath & Beyond (BBBY)
1.5515 of 5 stars
$5.25-19.6%N/A-0.91Reduce$7.67
Compare These Stocks  Add These Stocks to My Watchlist 

Should you invest $1,000 in Bed Bath & Beyond right now?

Before you consider Bed Bath & Beyond, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bed Bath & Beyond wasn't on the list.

While Bed Bath & Beyond currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The 5 Stocks Here

Free Email Newsletter

Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:


Most Read This Week

Recent Articles

Search Headlines:

Latest PodcastHow to Profit In The Bear Market

Today, Kate is joined by a repeat guest, Rob Isbitts of Sungarden Investment Publishing. Rob specializes in ETF portfolios designed to deliver returns in any kind of market condition, including the current bear. In this conversation, Rob gives specific ideas for handling various allocations in your portfolio, and discusses how to approach inverse ETFs.

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.